Teethgrinder – Lifestyle
Author:
Alzheimer’s Drug Discovery Foundation
Goodes Prize Recipient Dr. Jeff Cummings’ 2026 Alzheimer’s Drug Pipeline Report Signals New Era of Biology-Driven Approaches
May 5, 2026
ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer’s Precision Medicine Worldwide
March 17, 2026
Alzheimer’s Drug Discovery Foundation Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer’s Breakthroughs
March 11, 2026